174 related articles for article (PubMed ID: 29175214)
1. Survival in patients with primary dermatofibrosarcoma protuberans: National Cancer Database analysis.
Trofymenko O; Bordeaux JS; Zeitouni NC
J Am Acad Dermatol; 2018 Jun; 78(6):1125-1134. PubMed ID: 29175214
[TBL] [Abstract][Full Text] [Related]
2. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.
DuBay D; Cimmino V; Lowe L; Johnson TM; Sondak VK
Cancer; 2004 Mar; 100(5):1008-16. PubMed ID: 14983497
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Factors, Treatment, and Survival in Dermatofibrosarcoma Protuberans.
Criscito MC; Martires KJ; Stein JA
JAMA Dermatol; 2016 Dec; 152(12):1365-1371. PubMed ID: 27262160
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change.
Liang CA; Jambusaria-Pahlajani A; Karia PS; Elenitsas R; Zhang PD; Schmults CD
J Am Acad Dermatol; 2014 Oct; 71(4):781-6. PubMed ID: 24755121
[TBL] [Abstract][Full Text] [Related]
5. Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery.
Paradisi A; Abeni D; Rusciani A; Cigna E; Wolter M; Scuderi N; Rusciani L; Kaufmann R; Podda M
Cancer Treat Rev; 2008 Dec; 34(8):728-36. PubMed ID: 18684568
[TBL] [Abstract][Full Text] [Related]
6. Nonmelanoma skin cancer.
Lee DA; Miller SJ
Facial Plast Surg Clin North Am; 2009 Aug; 17(3):309-24. PubMed ID: 19698913
[TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary approach to the management of dermatofibrosarcoma protuberans.
Buck DW; Kim JY; Alam M; Rawlani V; Johnson S; Connor CM; Dumanian GA; Wayne JD
J Am Acad Dermatol; 2012 Nov; 67(5):861-6. PubMed ID: 22387033
[TBL] [Abstract][Full Text] [Related]
8. Dermatofibrosarcoma protuberans: long-term outcomes of 53 patients treated with conservative surgery and radiation therapy.
Castle KO; Guadagnolo BA; Tsai CJ; Feig BW; Zagars GK
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):585-90. PubMed ID: 23628134
[TBL] [Abstract][Full Text] [Related]
9. Dermatofibrosarcoma protuberans with fibrosarcomatous transformation: our experience, molecular evaluation of selected cases, and short literature review.
Lopez LV; Yatsenko SA; Burgess M; Schoedel K; Rao UNM
Int J Dermatol; 2019 Nov; 58(11):1246-1252. PubMed ID: 30968395
[TBL] [Abstract][Full Text] [Related]
10. Dermatofibrosarcoma protuberans: A retrospective study of clinicopathologic features and related Akt/mTOR, STAT3, ERK, cyclin D1, and PD-L1 expression.
Park S; Cho S; Kim M; Park JU; Jeong EC; Choi E; Park JH; Lee C; Chang MS
J Am Acad Dermatol; 2018 Nov; 79(5):843-852. PubMed ID: 29792909
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of surgical treatment for dermatofibrosarcoma protuberans according to width of gross resection margin.
Woo KJ; Bang SI; Mun GH; Oh KS; Pyon JK; Lim SY
J Plast Reconstr Aesthet Surg; 2016 Mar; 69(3):395-401. PubMed ID: 26646402
[TBL] [Abstract][Full Text] [Related]
12. Imatinib Treatment for Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans: A Systematic Review.
Navarrete-Dechent C; Mori S; Barker CA; Dickson MA; Nehal KS
JAMA Dermatol; 2019 Mar; 155(3):361-369. PubMed ID: 30601909
[TBL] [Abstract][Full Text] [Related]
13. [Dermatofibrosarcoma protuberans: Surgical margins using Slow-Mohs micrographic surgery. A clinical retrospective study about 20 cases].
Verbruggen C; Ricard AS; Cogrel O; Bondaz M; Carrier S
Ann Chir Plast Esthet; 2018 Feb; 63(1):47-53. PubMed ID: 28755830
[TBL] [Abstract][Full Text] [Related]
14. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature.
Snow SN; Gordon EM; Larson PO; Bagheri MM; Bentz ML; Sable DB
Cancer; 2004 Jul; 101(1):28-38. PubMed ID: 15221986
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional histology for dermatofibrosarcoma protuberans: case series and surgical technique.
Irarrazaval I; Redondo P
J Am Acad Dermatol; 2012 Nov; 67(5):991-6. PubMed ID: 22657156
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy in the treatment of dermatofibrosarcoma protuberans.
Dagan R; Morris CG; Zlotecki RA; Scarborough MT; Mendenhall WM
Am J Clin Oncol; 2005 Dec; 28(6):537-9. PubMed ID: 16317260
[TBL] [Abstract][Full Text] [Related]
17. Dermatofibrosarcoma Protuberans: A Clinicopathologic and Therapeutic Analysis of 254 Cases at a Single Institution.
Jing C; Zhang H; Zhang X; Yu S
Dermatol Surg; 2021 Feb; 47(2):e26-e30. PubMed ID: 32769521
[TBL] [Abstract][Full Text] [Related]
18. 3D-Histological evaluation of surgery in dermatofibrosarcoma protuberans and malignant fibrous histiocytoma: differences in growth patterns and outcome.
Häfner HM; Moehrle M; Eder S; Trilling B; Röcken M; Breuninger H
Eur J Surg Oncol; 2008 Jun; 34(6):680-6. PubMed ID: 17716851
[TBL] [Abstract][Full Text] [Related]
19. Retrospective Analysis of a Modern Cohort of Dermatofibrosarcoma Protuberans From 2000 to 2018.
Baig IT; Lauck K; Nguyen QD
J Cutan Med Surg; 2023; 27(2):108-116. PubMed ID: 36655601
[TBL] [Abstract][Full Text] [Related]
20. Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution.
Bowne WB; Antonescu CR; Leung DH; Katz SC; Hawkins WG; Woodruff JM; Brennan MF; Lewis JJ
Cancer; 2000 Jun; 88(12):2711-20. PubMed ID: 10870053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
